Vol 7, No 7, January - March 7998 Endometrial biopsy
collection
25Endometrial
biopsy collection from
women
receiving Norplant@
Wachyu Hadisaputra,
Biran Affandi,
PeterA.W.
Rogers*
Abstrak
Dalam upaya melakukaneksplorasipenyebabperdarahansebagai efeksamping utama dariwanitapengguna implan dilndonesia, maka Pokja
Reproduksi
nesia melakukan beberapa penelitian dasar yang salah satunya adalah penelitian biopsi endometrium.tlntuk
itu
biopsi end,ometrium terhadap 191 wanita pemakai kontrasepsi Norplant@ dengan lama pemakaian antara 2 dan 72 bulan. Delapan puluh tujuh biopsi dilakukan dengan menggunakan mikrohisteroskopi, ilan 104 biopsi dilakukan dengan memakai kanula Pipelle atau kanula Karman dengan metod.e aspirasi.Dari hasil biopsi histeroskopi, hanya
50Vo sampel dapat dianalisis adanya sel endometium, oleh karena sering didapatkan hanya miometrium dari sampel tersebut. Pada metod.a biopsi dengan kanula baik Karman maupun Pipelle tidak sampai mencapai miomelrium. Sedangkan pada analisis kadar estrogen, didapat perbedaan bermakna antara kadar estrogen pada biopsi hari ke90
ri ke 14, yaitu masing-masing (26,5 a2r1 v 16,2 + 1,8 pmol/lP=0,0003) d.an (4j9 + 35 v 289 +j
j
pmolll P=0,0018).Di
s etelah 3-12 bulan pemakaianNorplant@,50Vo menunjukkan endometrium yanç sangat tipis untuk dapat diambil sampelnya. Dengan gambaran klinis kad.ar estrogen yant sangat rendah dan berkurangnya darah haid.
Abstract
This paper reports a series of 191 endometrial biopsy procedures performed on Indonesian women who had received between 3 and 12 months
"*pà.u."
to Norplant@.87 biopsy procedures were attempted witb a microhysteroscope using biopsy forceps, and 104 procedures were attempted with either Pipelle or Karman suction curettes. Regardless of biopsy method, diagnosable endometrium was only obtained in approximately 5O7o olprocedures. Myometrium was often found in microhysteroscope but notsuction biopsies. Analysisof a number oF clinical characteristics showed that women from whom diagnosable endometrial tissue was obtained had higher mean peripheral oestrogen levels in the 2 weeks prior to biopsy (439 + 35 v 289 9 33 pmol/. P=0.0018), and significantly more days when endometrial bleeding occurred in the 90 days prior to biopsy (26.5 + 2.1
v
16.2 11.8. P=0.0003). These results suggest that after 3-12 months exposure to Norplant* about 5OVo of women have an endometrium that too thin to sample, and that this group is characterised by lower peripheral oestrogen levels and reduced menstrual bleeding.Keywords: endometrial biopsy, Karman cannula, microhysteroscope, Norplant@, Pipelle suction curette.
Prolonged and/or irregular
breakthrough bleeding
isone
of
the
major
complications
of
most
progestogen-only
contraceptive.
In
particular,
a significant numberof
women using
thesubdermal contraceptive implant,
Norplant@,
is siriously
inconvenienced
by
unwantedalterations
in
menstrual bleeding pattern.
Recently,research
into
the
causes
of
Progestogen-induced
breakthrough bleeding
has focused on therole
oflocal
factors acting
within
theendometrium. In
the absenceof
goodanimal models, this
work has been
carriedout
almost
entirely
on
endometrial
biopsy
samples
ob-tainedfrom women
usingprogestogen-only
contracep-tive
methods.
In
a
majority
of the
patients
using
Department of Obstetrics and Gynaecology, Faculty of
Medicine, University of Indonesia, Jakarta, Indonesia * Department of Obstetrics and Gynàecology, Monash Univers ity, Melbourne, Australia
Norplant
contraception,
drop out is
due
to
menstrual disorders(menorrhagia, spotting etc.). This
paperwill
very
briefly
describe
the endometrial biopsy
proce-dures andresults
from
Raden SalehKlinik
in Jakarta
where
agroup
of 191
women underwent endometrial
biopsy
following
3-12
months
of
exposure to
Nolplant-.
The
aim of this
study
is to
compare
threedifference methods
of biopsy,
i.e.
Hysteroscopy,
Pipelle biopsy and Karman cannula, in
getting
accurate tissue samples.METHODS
Three
different
outpatient endometrial
biopsy
techni-ques
were
utilised
in
this study.
The
first
was
rnicrohysteroscopy,
the
second
was Pipelle
suction
curette(Prodimed
60530,Neuilly-en- Thelle,
France)26 Hadisaputra et al.
Storz
hysterescopewith
a
30oangle
of view.
Carbondioxide
was usedto distend
theuterine cavity
andthis
was delivered
by
a
Hamou hysteroflator.
Prior
tohysteroscopy,
the external cervical os
was
exposed,wiped
clear of mucous and swabbedwith mild
antisep-tic
(providone
iodine,
lOTo). 5-L0ml of
l7o lignocaine
wasinfiltrated
into
theanterior
lip
of cervix
toprovide
local
anaesthesia.
Small
rigid
biopsy forceps
wereinserted
through the
operative canal
on the
hystero-scope
into the
distended
uterine cavity.
Endometrial
biopsy was performed either under direct vision
or
fromvideo
imagesona
nearlymonitor.
Preparationfor
biopsies
with
either thePipelle
orKarman
cannula wasessentially
similar to that
for
microhysteroscopy
ex-cept
that no local
anaesthetic was
used.The
Pipelle
suction
curette is a narrowflexible
device that iswide-ly
usedfor
out-patieht endometrial biopsy
procedures. TheKarman cannula
is 4 mm in diameter and madeof
flexible
polyethylene. Suction is provided by
attaching a standard disposablesyringe.
These
procedures were performed on volunteers who
had
consented
to
take part
in
a WHO
funded
andethically
approved study,
without
anaesthetic.A
total
of
191 women who hadieceived
an average Nolplant@exposure
of 2I9 +
7.2
days (mean
+
S.E.M)
arereported
in
this study.
The
averageweight of
thesewomen was'51
+
0.7kg,
the
average agewas 30
+
0.3
years, and eachwoman
hadan
avera9eof
2.6
+
0.1 pregnancies.Endometrial
biopsies were taken
by 2
operators, over
aperiod of
almost
3 yean.
All
endometrial materials
obtainedfrom
eachprocedure were
immediately
transferred
tothe
laboratory
and
processedusing buffered
formalin
fixation, prior
towax
embedding and routinehistologi-cal
examination. Biopsies
were sceened by at leasttwo
people
for
evaluation
of
diagnosable endometrial
tis-sue.
All
subjects completed
adaily
menstrual record
cardfor at
least 90
prior to
biopsy, recording
bleeding,
spotting
or
no bleeding
for
each
day. Bleeding
andspottirig
dayswere combined for
the analysis togive
afigure for total
number
of
bleeding
andspotting
daysduring
the 90 daysprior
tobiopsy. In the 2
weeksprior
to
biopsy, six
peripheral
blood
sampleswere
taken at2-3
day intervals
to
evaluate circulating
oestradiol
concentratiorrs
(Coat-A-Count
Oestradiol; Diagnostic
Products Corporation,
L,os Angeles, CA,USA; coeffi:
cients
of
variation, intra-assay 5.6%
at
290 pglml,
interassay 5.57o at 262 p glml).
Med J Ind.ones
RBSULTS
The
results
for
191
biopsy
procedures
are given in
Table 1.
In
summary,
from
87 biopsies
with
amicrohysteroscope,
5l7o prodlced
endometrial
tis sue thatcould
be adequately evaluatedby
histopathology.
Using either
a
Pipelle or Karman
cannula,
from
104 procedures,exactly
5O%ofbiopsies
produced
enough diagnosableendometrial
tissue.Table 1. Results for 191 endometrial biopsy procedures using either
a
microhysteroscope,or
Pipelleor
Karman cannula. Operator 1 performed all microhysteroscope procedure (N = 87)while
2
operators (1 and2)
per-formed the remaining 104 procedures using either a Pipelle or Karman.Microhysteroscope Pipelle / Karman
Operator
22 (42%) 30 (s8%) Diagnosable
endometrial tissue
Myometrium only
Inadequate or no tissue
44 (st%)
40 (46%)
3 (3Vo) 30 (s8%) 22 (42%)
Totals 81(rOO%)
52(tooVo)
52(tooVo)ln
a subsequent studyby a
third
operator, only
5 outof
30 (l7Eo)
biopsies
taken using
a
microhysteroscope
had adequate tissuesfor
diagnosis.
However,
105out
of
152 (697o)biopsies taken
with
aKarman
cannulaproduced suitable tissues
for
histopathological
diag-nosis.The use of the
microhysteroscope often
resultedin
full
thickness
endometrium being collected,
including
a small amount ofmyometrial
tissue.Histologial
evalua-tion of
these
full
thickness biopsies showed
that
theendometrium
wasalways
very thin or
absent.In
con-trast,
both the Pipelle
and
the Karman collected
en-dometrial
tissueonly. Where a biopsy
was successful,there
was often
a
relatively large amount
of
tissuebroken into small and medium size
fragments
con-tainedwithin
blood
and mucous.However
inthe
50Voof
biopsies where no tissue wasobtained,
mucous andBiopsy No Biopsy
26.5 + 2.1
L6.2 + 1.8
439 + 35
289 + 33
Vol 7, No 7, January - March 1998
In
abrief
analysis
of
anumber
of clinical
parameters, somesignificant
differences
were found between thosepatients
from
whom
a successfulbiopsy
was obtained, and thosefrom whom
noendometrium
was collected.These data are
listed
in
Table 2
and
show very
sig-nificant
differences in
bothbleeding
days, and averageperipheral
estrogen levels betweenwomen
fromwhom
endometrial
tissue was obtained and thosefrom whom
lissue was
not
obtained. Similar
analyses
for
body
weight
and
length of
Norplant@""porur"
showed
nosignificant
differences
between thetwo
groups.Table 2. Differences
in
bleeding days, (numberof
days inwhich
bleedingor
spoting were recordedin
the90
days
prior to
biopsy), and average peripheralestrogen levels (based on 6 bloods taken during the 2 weeks prior to endometrial biopsy) between women from whom a n endometrial biopsy was obtained, and
women
from whom
no
endometrial tissue wasobtained (values are mean + SEM).
N
BleedingDays
Average Estrogen(pmol/l)
Endometrial biopsy
collection
27which
nobiopsy
wasobtained,
is somewhatsuprising.
This
suggests that womentaking Norplant from whom
succesful endometrial biopsies
were
obtained
arenot
representative
of
the
whole
population,
but
rather
define
asub- group that have an
averâgeof
ahigher
level
of
bleeding, and
greater endogenous
estrogen levels.This
information
needs to be consideredwhen-ever analysis
of clinical
data isundertaken for women
from which
biopsies r,ryeresuccessfully obtained.
In
conclusion,
this
short paper outlines the typical
success rate
that
can beanticipated when endornetrial
biopsies are
being
obtained
from women during
thefirst
year of Norplant@ use.It
also demonstratesfor
thefirst
time, that
thegroup
from which
successful
biop-sies are obtained may not be
representative
of
thewhole population,
and
this
issue
should
be
borne in
mind during further
analysesof clinical
parameters.Acknowledgements
This
work
wassupported
by World Health
Organisa-tion
project grant Nos. 90901 and 92909
through
theWHO
Special Programme
of
Research,Development
and Research
Training
in
Human Reproduction.
Thanks are due
to Dr.
Julia-_ntçWitjaksono,
Beatrics
Susil
for
histopathological
assessmentof
endometrial
section,
Sr.
Rosminah
Hubardina
Animo for
patient
coordination, Ida
Iriani
andYudiati for
expert
techni-cal
assistance.REFERENCES
1.
Fraser IS. A survey of different approaches te managementof
menstrual disfurbancesin
women using injectable con-traceptives. Contraception, 1983;28 :385-99.2.
hu
TM, Witjaksono J, Affandi B, Rogers pAW. Expressionof progesterone receptor mRNA in the endometrium during
the normal menstrual cycle and
in
Norplant@ users. FIumReprod 11, 1996.
3.
Marsh MM, Butt AR, Riley SC et al. Immunolocalization of endothelin and neural endopeptidase in the endometrium ofusers of subdermally implated levonorgestrel (Norplant@).
Hum Reprod 1995;lO:2584-9.
4.
OdlinV,
Fraser IS. Contraception and menstrual bleeding disturbances; a clinical overview. Inn D'Arcangues C, FraseiIS,
NewtonJR
andOdlin
V
(eds). Contraception andMechanism of Endometrial Bleeding. Cambridge University
Press, Cambridge, UK, l990;p. 5 -32.
5.
RogersPAW,
Au
CL,
Affandi B.
(1993) Endomerrial microvascular density during the normal menstrual cycle andfollowing exposure to long-term levonorgstrel. Hum Reprod
1993;8:1396-993.
6.
Saaban MM, SI el-Kabsh MY etal.
Effect of levonorgestrel contraceptive implant, Norplant, on blood coagulation. Con_ traception L98 4;30 : 421 -3O.88
93
P Value
DISCUSSION
The results
from this
study show that
in
women who
have
received
Norplant@éontraception
for
between 3 and 12months,
only
about 507o have anendometrium
that can be biopsied. These results
suggest
that in
approximately
5O7o of thesewomen,
there isvery
little
or no
endometrium present. There may
besome
dif-ferences depending
on the
experience
of
individual
operators.
The
microhysteroscope
provides
a
small
biopsy
that
usually
contains
full
thickness
en-dometrium.
Theepithelium
is oftenmissing from
the sebiopsies, presumably due
to
shearing
damageduring
the
biopsy procedure.
In
contrast, thePipelle
andKar-man cannula often provide quite large
amounts
of
tissue, although
this
may be broken
into
numerousfragments and
often
combined
with
large
amountsof
blood.
It
is
much more
difficult to
orient the
tissueobtained
from
the
Pipelle or
Karman cannula biopsy
cornpared
to
thoseobtained by microhysteroscopy.
The
finding
of
significant
differences in
bothbleeding
days and
averageestrogen levels
betweenthe
groupsfrom which
abiopsy was obtained
versus thosefrom
28
Hadisaputra et al. Med J Indones7.
Sivin
R.
Contraceptlonwith
Norplant@ implants.Hum
explants fmm women using Norplanto contraception. Hum Reprod1984;9:1818-26.
Reprod 1995;lO:2579-83.